City Therapeutics Inc. logo

City Therapeutics Inc.

CTY | NASDAQ
Chart Builder DCF Calculator
$20.99
+$0.28 (+1.35%)
Nov 2, 2026, 1:17 PM ET · Market open
TTM
Period Ending
Q2 2020
Jun 30, 2020
Q1 2020
Mar 31, 2020
Q4 2019
Dec 31, 2019
Q3 2019
Sep 30, 2019
Q2 2019
Jun 30, 2019
Q1 2019
Mar 31, 2019
Q4 2018
Dec 31, 2018
Q3 2018
Sep 30, 2018
Q2 2018
Jun 30, 2018
Q1 2018
Mar 31, 2018
Q4 2017
Dec 31, 2017
Q3 2017
Sep 30, 2017
Q2 2017
Jun 30, 2017
Q1 2017
Mar 31, 2017
Q4 2016
Dec 31, 2016
Q3 2016
Sep 30, 2016
Q2 2016
Jun 30, 2016
Q1 2016
Mar 31, 2016
Q4 2015
Dec 31, 2015
Q3 2015
Sep 30, 2015
Q2 2015
Jun 30, 2015
Q1 2015
Mar 31, 2015
Cash & Equivalents
5M 8M 2M 3M 7M 9M 5M 6M 11M 6M 1M 4M 6M 18M 5M 7M 4M 4M 3M 9M 6M 6M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
185M 565M 515M 785M 879M 993M 407M 1.13B 1.24B 463M 454M 487M 516M 542M 567M 603M 637M 669M 705M 717M 2.78B 2.92B
Receivables
413M 470M 514M 505M 526M 539M 546M 592M 562M 577M 646M 684M 620M 637M 700M 679M 688M 676M 688M 706M 693M 709M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
623M 846M 1.97B 1.75B 1.6B 1.42B 1.3B 947M 1.9B 1.36B 1.12B 974M 971M 1.09B 1B 1.11B 959M 1.33B 911M 1.67B 1.5B 1.39B
Total Current Assets
1.04B 1.32B 2.49B 2.25B 2.13B 1.97B 1.85B 1.55B 2.47B 1.94B 1.77B 1.66B 1.6B 1.74B 1.71B 1.8B 1.65B 2.01B 1.6B 2.39B 2.2B 2.11B
Property-Plant & Equipment
8.29B 8.21B 8.17B 8.1B 8.03B 8.01B 8.08B 7.94B 7.94B 7.95B 7.92B 7.94B 7.81B 7.67B 7.65B 7.51B 7.44B 7.41B 7.37B 7.29B 7.22B 7.18B
Goodwill & Intangibles
9.93B 9.67B 9.83B 9.69B 9.7B 9.72B 10.25B 9.69B 9.7B 10.6B 10.72B 10.85B 10.97B 11.1B 11.23B 11.37B 11.5B 11.65B 11.79B 11.94B 10.06B 10.11B
Total Long-Term Assets
18.41B 18.45B 18.51B 18.58B 18.61B 18.72B 18.74B 18.76B 18.89B 19.01B 19.1B 19.28B 19.3B 19.31B 19.44B 19.48B 19.58B 19.72B 19.87B 20.11B 20.22B 20.39B
Total Assets
19.45B 19.77B 21B 20.83B 20.74B 20.68B 20.58B 20.31B 21.36B 20.95B 20.87B 20.94B 20.89B 21.06B 21.15B 21.27B 21.23B 21.73B 21.47B 22.5B 22.42B 22.49B
Account Payables
288M 347M 403M 412M 345M 366M 441M 298M 289M 300M 317M 366M 358M 430M 398M 377M 350M 445M 369M 491M 478M 482M
Deferred Revenue
185M 200M 201M 205M 223M 221M 212M 249M 209M 101M 128M 130M 125M 128M 131M 121M 123M 124M 137M 161M 321M 329M
Short-Term Debt
302M 3M 1.11B 7M 9M 9M 11M 13M 15M 17M 17M 24M 17M 515M 514M 509M 509M 243M 242M 644M 248M 112M
Other Current Liabilities
1.62B 1.66B 1.7B 1.6B 1.6B 1.59B 1.61B 1.57B 1.56B 1.7B 1.73B 1.68B 1.67B 1.65B 1.75B 1.71B 1.67B 1.71B 1.67B 1.62B 1.35B 1.43B
Total Current Liabilities
2.39B 2.21B 3.41B 2.23B 2.18B 2.19B 2.27B 2.13B 2.07B 2.12B 2.2B 2.2B 2.17B 2.72B 2.8B 2.72B 2.66B 2.52B 2.42B 2.92B 2.4B 2.35B
Long-Term Debt
4.36B 4.85B 4.85B 5.95B 5.95B 5.95B 5.95B 5.95B 7.26B 7.26B 7.26B 7.26B 7.27B 6.75B 6.75B 6.75B 6.73B 7.22B 7B 7.12B 7.11B 7.36B
Other Long-Term Liabilities
714M 518M 515M 559M 557M 550M 547M 448M 341M 80M 82M 90M 91M 86M 66M 55M 61M 56M 60M 61M 67M 79M
Total Long-Term Liabilities
6.26B 6.67B 6.67B 7.61B 7.63B 7.66B 7.68B 7.59B 8.77B 8.44B 8.48B 9.17B 9.19B 8.7B 8.72B 8.77B 8.77B 9.28B 9.09B 9.32B 9.39B 9.75B
Total Liabilities
9.32B 9.66B 10.88B 10.62B 10.61B 10.68B 10.72B 10.49B 11.66B 11.4B 11.53B 12.25B 12.27B 12.35B 12.46B 12.47B 12.43B 12.82B 12.56B 13.51B 13.05B 13.36B
Total Debt
4.66B 4.85B 5.95B 5.95B 5.96B 5.96B 5.96B 5.96B 7.28B 7.28B 7.28B 7.29B 7.28B 7.26B 7.26B 7.26B 7.24B 7.46B 7.24B 7.76B 7.36B 7.47B
Book Value
10.12B 10.12B 10.12B 10.21B 10.13B 10.01B 9.87B 9.82B 9.7B 9.55B 9.34B 8.69B 8.63B 8.71B 8.69B 8.8B 8.8B 8.91B 8.91B 8.99B 9.37B 9.13B
Book Value Per Share
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B 10.05B
Retained Earnings
73M 68M 67M 159M 82M -45M -182M -231M -353M -505M -713M -1.36B -1.42B -1.34B -1.36B -1.25B -1.25B -1.14B -1.14B -1.06B -682M -920M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3M n/a n/a n/a n/a
Shareholders Equity
10.12B 10.12B 10.12B 10.21B 10.13B 10.01B 9.87B 9.82B 9.7B 9.55B 9.34B 8.69B 8.63B 8.71B 8.69B 8.8B 8.8B 8.91B 8.91B 8.99B 9.37B 9.13B
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.